AP
Anasuya Panyala
About Anasuya Panyala
Data last updated:
Anasuya Panyala is a Director at Velzen Pharma Private Limited (since 2022). The companies operate in Pharma. Velzen Pharma Private Limited reported revenue of ₹2.07 Cr (FY 2025). Earlier, Anasuya Panyala was a Director at Velzen Pharma Private Limited (2022–2026).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Velzen Pharma Private Limited U24239TG2022PTC161052 | Director | 30 Mar 2022 | 2022 | ₹2.07 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Velzen Pharma Private Limited U24239TG2022PTC161052 | Director | 30 Mar 2022 | 2022 | ₹2.07 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anasuya Panyala
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kalpana Ravanaboina | 07493647 | Velzen Pharma Private Limited | Director |
| Kirankumar Velaveni | 06992040 | Velzen Pharma Private Limited | Director |
| Sanjay Verma | 09553514 | Velzen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anasuya Panyala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anasuya Panyala
Anasuya Panyala currently holds 1 directorship: Velzen Pharma Private Limited (Director, since 30 Mar 2022, revenue ₹2.07 Cr (FY 2025)).
Anasuya Panyala was first appointed on 30 Mar 2022 as Director at Velzen Pharma Private Limited.
Anasuya Panyala held 1 earlier board appointment: Velzen Pharma Private Limited (Director, 30 Mar 2022 to 27 Aug 2026).
The current boards of Anasuya Panyala's companies include Kalpana Ravanaboina (Velzen Pharma Private Limited), Kirankumar Velaveni (Velzen Pharma Private Limited), Sanjay Verma (Velzen Pharma Private Limited).